Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial (Q43951696)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q42315566)
(Q41044549)
(Q39032761)
(Q39693505)
(Q38544864)
(Q16299408)
(Q58374260)
(Q37069167)
(Q38291860)
(Q88043810)
(P304) 1544-1550
(P407) (Q1860)
(P433) 8
(P478) 25
(P577) Friday, March 7, 2014
(P921) (Q715347)
(Q128581)
(Q412616)
(P1433) (Q326122)
(P1476) "Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial" (language: en)
(P2093) R Salgado
N Sirtaine
D Fumagalli
P Bono
M J Piccart
C Sotiriou
other details